Banha-sasim-tang as an herbal formula for the treatment of functional dyspepsia: A randomized, double-blind, placebo-controlled, two-center trial

Trials

Volumn 11, Issue , 2010, Pages

  Park, Jae Woo ^a   Ryu, Bongha ^a   Yeo, Inkwon ^b   Jerng, Ui Min ^a   Han, Gajin ^a   Oh, Sunghwan ^a   Lee, Jinsoo ^a   Kim, Jinsung ^a  

^a Kyung Hee University   (South Korea)

^b Sookmyung Women's University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BANHA SASIM TANG; BANSASIN; HERBACEOUS AGENT; PLACEBO; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DYSPEPSIA; ELECTROGASTROGRAPHY; FEMALE; FOLLOW UP; FUNCTIONAL DYSPEPSIA; GASTROINTESTINAL SYMPTOM; HUMAN; MALE; MYOELECTRIC CONTROL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VISUAL ANALOG SCALE; HERBAL MEDICINE; KOREAN MEDICINE; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; PINELLIA; SOUTH KOREA; STATISTICAL ANALYSIS;

ADULT; AGED; DATA INTERPRETATION, STATISTICAL; DOUBLE-BLIND METHOD; DYSPEPSIA; FOLLOW-UP STUDIES; HERBAL MEDICINE; HUMANS; MEDICINE, KOREAN TRADITIONAL; MIDDLE AGED; PINELLIA; PLACEBOS; QUALITY OF LIFE; REPUBLIC OF KOREA; YOUNG ADULT;

EID: 77954996958     PISSN: 17456215     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-11-83     Document Type: Article

References (30)

1. Madisch A, Holtmann G, Mayr G, Vinson B, Hotz J. Treatment of functional dyspepsia with a herbal preparation. A double-blind, randomized, placebo-controlled, multicenter trial. Digestion 2004, 69:45-52. 10.1159/000076546, 14755152.
2. von Arnim U, Peitz U, Vinson B, Gundermann KJ, Malfertheiner P. STW 5, a phytopharmacon for patients with functional dyspepsia: results of a multicenter, placebo-controlled double-blind study. Am J Gastroenterol 2007, 102:1268-1275. 10.1111/j.1572-0241.2006.01183.x, 17531013.
3. Drossman DA, Li Z, Andruzzi E, Temple RD, Talley NJ, Thompson WG, Whitehead WE, Janssens J, Funch-Jensen P, Corazziari E, Richter JE, Koch GG. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 1993, 38(9):1569-1580. 10.1007/BF01303162, 8359066.
4. Lee JS. The guideline for diagnosis of functional dyspepsia. Kor J Neuroenterol Motil 2005, 11(3):18-24.
5. Sha W, Pasricha PJ, Chen JD. Correlations among electrogastrogram, gastric dysmotility, and duodenal dysmotility in patients with functional dyspepsia. J Clin Gastroenterol 2009, 43(8):716-722. 10.1097/MCG.0b013e31818b8ed9, 19247205.
6. van der Voort IR, Osmanoglou E, Seybold M, Heymann-Mönnikes I, Tebbe J, Wiedenmann B, Klapp BF, Mönnikes H. Electrogastrography as a diagnostic tool for delayed gastric emptying in functional dyspepsia and irritable bowel syndrome. Neurogastroenterol Motil 2003, 15(5):467-473. 10.1046/j.1365-2982.2003.00433.x, 14507348.
7. Wang ZS, Elsenbruch S, Orr WC, Chen JD. Detection of gastric slow wave uncoupling from multi-channel electrogastrogram: validations and applications. Neurogastroenterol Motil 2003, 15(5):457-465. 10.1046/j.1365-2982.2003.00430.x, 14507347.
8. Talley NJ, Meineche-Schmidt V, Paré P, Duckworth M, Räisänen P, Pap A, Kordecki H, Schmid V. Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies). Aliment Pharmacol Ther 1998, 12(11):1055-1065. 10.1046/j.1365-2036.1998.00410.x, 9845395.
9. Holtmann G, Gschossmann J, Mayr P, Talley NJ. A randomized placebo-controlled trial of simethicone and cisapride for the treatment of patients with functional dyspepsia. Aliment Pharmacol Ther 2002, 16(9):1641-1648. 10.1046/j.1365-2036.2002.01322.x, 12197843.
10. Froehlich F, Gonvers JJ, Wietlisbach V, Burnand B, Hildebrand P, Schneider C, Saraga E, Beglinger C, Vader JP, . Eradication in Dyspepsia (ERADYS) Study Group Helicobacter pylori eradication treatment does not benefit patients with nonulcer dyspepsia. Am J Gastroenterol 2001, 96(8):2329-2336. 10.1111/j.1572-0241.2001.04037.x, 11513170, Eradication in Dyspepsia (ERADYS) Study Group.
11. Zhao L, Gan AP. Clinical and Psychological assessment on Xinwei decoction for treating functional dyspepsia accompanied with depression and anxiety. Am J Chin Med 2005, 33(2):249-257. 10.1142/S0192415X05002801, 15974484.
12. Zheng H, Tian XP, Li Y, Liang FR, Yu SG, Liu XG, Tang Y, Yang XG, Yan J, Sun GJ, Chang XR, Zhang HX, Ma TT, Yu SY. Acupuncture as a treatment for functional dyspepsia: design and methods of a randomized controlled trial. Trials 2009, 10:75. 10.1186/1745-6215-10-75, 2736949, 19698147.
13. Oikawa T, Ito G, Hoshino T, Koyama H, Hanawa T. Hangekobokuto (Banxia-houpo-tang), a Kampo Medicine that Treats Functional Dyspepsia. Evid Based Complement Alternat Med 2009, 6(3):375-378. 10.1093/ecam/nem101, 2722198, 18955239.
14. Bortolotti M, Coccia G, Grossi G, Miglioli M. The treatment of functional dyspepsia with red pepper. Aliment Pharmacol Ther 2002, 16(6):1075-1082. 10.1046/j.1365-2036.2002.01280.x, 12030948.
15. Holtmann G, Adam B, Haag S, Collet W, Grünewald E, Windeck T. Efficacy of artichoke leaf extract in the treatment of patients with functional dyspepsia: a six-week placebo-controlled, double-blind, multicentre trial. Aliment Pharmacol Ther 2003, 18(11-12):1099-1105. 10.1046/j.1365-2036.2003.01767.x, 14653829.
16. Kupcinskas L, Lafolie P, Lignell A, Kiudelis G, Jonaitis L, Adamonis K, Andersen LP, Wadström T. Efficacy of the natural antioxidant astaxanthin in the treatment of functional dyspepsia in patients with or without Helicobacter pylori infection: A prospective, randomized, double blind, and placebo-controlled study. Phytomedicine 2008, 15(6-7):391-399. 10.1016/j.phymed.2008.04.004, 18467083.
17. World Health Organization WHO International Standard Terminologies on Traditional Medicine in the Western Pacific Region 2007, WHO Library Cataloguing in Publication Data, World Health Organization.
18. Naito T, Itoh H, Yasunaga F, Takeyama M. Hange-shashin-to raises levels of somatostatin, motilin, and gastrin in the plasma of healthy subjects. Biol Pharm Bull 2002, 25(3):327-331. 10.1248/bpb.25.327, 11913527.
19. Naito T, Itoh H, Takeyama M. Some gastrointestinal function regulatory Kampo medicines have modulatory effects on human plasma adrenocorticotropic hormone and cortisol levels with continual stress exposure. Biol Pharm Bull 2003, 26(1):101-104. 10.1248/bpb.26.101, 12520183.
20. Naito T, Itoh H, Takeyama M. Comparison of the effects of hange-shashin-to and rikkunshi-to on human plasma calcitonin gene-related peptide and substance P levels. Biol Pharm Bull 2003, 26(8):1104-1107. 10.1248/bpb.26.1104, 12913259.
21. Tack J, Talley NJ, Camilleri M, Holtmann G, Hu P, Malagelada J, Stanghellini V. Functional Gastroduodenal Disorders. Gastroenterology 2006, 130:1466-1479. 10.1053/j.gastro.2005.11.059, 16678560.
22. Adam B, Liebregts T, Saadat-Gilani K, Vinson B, Holtmann G. Validation of the gastrointestinal symptom score for the assessment of symptoms in patients with functional dyspepsia. Aliment Pharmcol Ther 2005, 22:357-363.
23. Kawashima K, Nomura A, Makino T, Saito K, Kano Y. Pharmacological properties of traditional medicine (XXIX): effect of Hange-shashin-to and the combinations of its herbal constituents on rat experimental colitis. Biol Pharm Bull 2004, 27(10):1599-1603. 10.1248/bpb.27.1599, 15467203.
24. Kase Y, Siatoh K, Makino B, Hashimoto K, Ishige A, Komatsu Y. Relationship between the antidiarrhoeal effects of Hange-Shashin-To and its active components. Phytother Res 1999, 13:468-473. 10.1002/(SICI)1099-1573(199909)13:6<468::AID-PTR504>3.0.CO;2-V, 10479755.
25. Lee EH, Hahm KB, Lee JH, Park JJ, Lee DH, Kim SK, Choi SR, Lee ST. Development and validation of a functional dyspepsia-related quality of life (FD-QOL) scale in South Korea. J Gastroenterol Hepatol 2006, 21(1 Pt 2):268-274. 10.1111/j.1440-1746.2006.04196.x, 16460485.
26. Sha W, Pasricha PJ, Chen JD. Rhythmic and spatial abnormalities of gastric slow waves in patients with functional dyspepsia. J Clin Gastroenterol 2009, 43(2):123-129. 10.1097/MCG.0b013e318157187a, 18719512.
27. Parkman HP, Hasler WL, Barnett JL, Eaker EY, . American Motility Society Clinical GI Motility Testing Task Force Electrogastrography: a document prepared by the gastric section of the American Motility Society Clinical GI Motility Testing Task Force. Neurogastroenterol Motil 2003, 15(2):89-102. 10.1046/j.1365-2982.2003.00396.x, 12680908, American Motility Society Clinical GI Motility Testing Task Force.
28. Verhagen MA, Van Schelven LJ, Samsom M, Smout AJ. Pitfalls in the analysis of electrogastrographic recordings. Gastroenterology 1999, 117(2):453-460. 10.1053/gast.1999.0029900453, 10419928.
29. Familoni BO, Bowes KL, Kingma YJ, Cote KR. Can transcutaneous recordings detect gastric electrical abnormalities?. Gut 1991, 32(2):141-146. 10.1136/gut.32.2.141, 1378795, 1864531.
30. Chen JD, Schirmer BD, McCallum RW. Serosal and cutaneous recordings of gastric myoelectrical activity in patients with gastroparesis. Am J Physiol 1994, 266(1 Pt 1):G90-98.